보성과학

비상장폐업자

Bosung Scientific Co., Ltd.

정호시

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

보성과학

Business Reg. No. 1188112790 · CEO 정호시

I.Investment Overview

Target보성과학 (1188112790)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명보성과학
영문명Bosung Scientific Co., Ltd.
대표자정호시
사업자등록번호1188112790
법인등록번호1101111207839
설립일1993.12.01

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW515.42020544.72021662.82022586.42023519.62024
영업이익100M KRW57.3202041.5202158202241.3202327.62024
순이익100M KRW48.8202065202146202232.9202320.12024
Item20242023202220212020
자산총계238.2억원234.4억원221.9억원211.7억원228.8억원
부채총계110.8억원112.1억원84.6억원90.4억원72.6억원
자본총계127.4억원122.3억원137.3억원121.3억원156.3억원
매출액519.6억원586.4억원662.8억원544.7억원515.4억원
영업이익27.6억원41.3억원58억원41.5억원57.3억원
순이익20.1억원32.9억원46억원65억원48.8억원

VI.Financial Ratios

FY2024 basis

5.31%

영업이익률

3.87%

순이익률

8.44%

ROA

15.79%

ROE

87.02%

부채비율

53.47%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

보성과학 투심보고서 | Alpha Lenz